[
  {
    "ts": "2026-02-23T17:00:44+00:00",
    "headline": "Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know",
    "summary": "A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court ruled the previous week that the president could not use the International Emergency Economic Powers Act (IEEPA) for such duties, a decision that had initially sent markets higher. However, the administration invoked a different authority, the Trade Act of 1974, to impose a 15% global tariff for up to",
    "url": "https://finance.yahoo.com/news/medpace-revvity-azenta-bio-techne-170044363.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "4e48f2b0-98e2-3f3a-bace-a7c8abffddf8",
      "content": {
        "id": "4e48f2b0-98e2-3f3a-bace-a7c8abffddf8",
        "contentType": "STORY",
        "title": "Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know",
        "description": "",
        "summary": "A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court ruled the previous week that the president could not use the International Emergency Economic Powers Act (IEEPA) for such duties, a decision that had initially sent markets higher. However, the administration invoked a different authority, the Trade Act of 1974, to impose a 15% global tariff for up to",
        "pubDate": "2026-02-23T17:00:44Z",
        "displayTime": "2026-02-23T17:00:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/3eaf0bbe0b017d0948c2e815889d12fe",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "MEDP Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V7NvVaOKM3JY2WZQT3zwEQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/3eaf0bbe0b017d0948c2e815889d12fe.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tESdZN5hbunlzYbFVbXz5w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/3eaf0bbe0b017d0948c2e815889d12fe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/medpace-revvity-azenta-bio-techne-170044363.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/medpace-revvity-azenta-bio-techne-170044363.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVTY"
            },
            {
              "symbol": "TECH"
            },
            {
              "symbol": "MEDP"
            },
            {
              "symbol": "AZTA"
            },
            {
              "symbol": "OSCR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]